Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You guys can't even break $1 on a day like this Harry? LOL
NEA just bought 4.35M shares at $1.25 Harry. Your theory is flawed....again. LOL
still, a welcome green in a sea of red today so far
F'n daytraders....
2M shares in 7 mins and up 9%. I concur.
With all eyes now on TIVO and its cocktail strategies and on the promising Ficlatuzamab news, an AV-353 partnership announcement & milestone would really stir the pot here, not to mention extending their cash runway farther along with the current offering. It sure appears that AVEO's at a very important apex right now. And I mean right now. Too many balls in the air and too much sustained volume to think otherwise.
you're not lovin' anything Harry. You are toast with the current 19% discount on shares below the new offering. It's like saying AVEO was going to .39 when they did the .50 offering several years ago. Live and learn Harry.
Max pain for 4/18 OPEX is $15. There will likely be some more short term algorithmic gyrations, but not for long: http://sweep.ly/maxpain.php?ticker=vff
43% of AVEO shareholders are institutions who aren't betting with Harry Crumb. Who's placed the more informed bet on FDA approval likelihood?
43% of AVEO is held by whales. Did you really just say that?
Hey harry, EUSA presenting P-3 data to CHMP this week in European Medicines Authority. You know what happens when EUSA submits to CHMP, right? Page 20. Going for 3rd line. https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-agenda-25-28-march-2019_en.pdf
Exactly, and all with an Aurora label.
So nobody wants to talk about ACB controlling a major Aussie grower's harvests for 5 years moving forward? I find this news from today/yesterday to be important. Locking up more oversea's supply is fundamentally key.
Expanding their supply chain down under: https://www.businessnewsaus.com.au/articles/cann-group-secures--11m-mildura-site-for-new-cannabis-greenhouse.html
Exactly. This thing's done for a while. CEO stuttering about dumping shares,EBITA losses up 750% on 203% rev growth. Undervalued VFF and ACB are where it;'s at now. TLRY did its thing back in October. $60 stock, tops.
I accept that idea rrten. Networking. What a killer day we have going here. Long and strong VFF. Sell order in between $36 and $37. However long it takes is fine.
That assumes that VFF management and its shareholders want to sell chunks of the company off and enter into LP's. That's definitely an avenue, but do you really think that's where VFF is headed? I would think if they need capital to expand, they'd look to venture capital firms instead. These funds typically buy major blocks of shares.
No, I don't accept that institutions are counting on establishing their stakes by picking up the daytraders' scraps on a tight float. That's preposterous. Yes, SP will increase exponentially with tute buying, but will VFF turn down additional big money that wants in and can't get in due to shortage of shares? Why can't we have a discussion about this without the condescending remarks like "Satisfied?"
What didn't you understand about me being long on VFF(and ACB)? You are alluding that I'm short. I have never shorted a stock...ever.
The fact is VFF's float is small...it's why I bought it. If they are going to attract institutional money, where are the shares going to come from? Please advise.
If VFF doesn't need cash, why are they presenting at an investor conference?
No, it's not a biotech. Thanks for the heads up on that. But it doesn't matter. If there's not enough float to satisfy institutional investment, companies typically have to create more shares if they want the cash infusion. It has nothing to do with sector.
142.5 to be exact
I am long VFF but just remember that investor conferences usually result in discounted offerings. I am a seasoned biotech investor and this is how it usually plays out. If they do an ATM, they will arrange to drop the SP in lieu of a private placement discount. Been there, done that. Happens all the time.
This deal is getting heavy protest. BMY should just buy some bargain companies like AVEO with pipelines that they could develop in short order with their resources.
Here we go Harry. You in?
LOL Harry. Show a time AVEO ever dipped below .55
This is a way oversold no brainer.
You're wrong Harry. Hope you covered your short. You're crazy if you didn't at its multi-year base support level.
Huge over reaction. Keep an eye out for this week's 13-F filings. Should know the story by Weds
Nice call
Yep, you saw that coming, right Harry? You working for NEA?
$20M EUSA payment for TIVO-3 data imminent. See page 25
https://www.ema.europa.eu/documents/agenda/agenda-chmp-agenda-28-31-january-2019_en.pdf
Bat, you gotta remember
Twisted Freak?
You were hittin' the nitrous a little hard back then Doc. I'm sorry about your loss. A securities attorney may want to take a sniff around all of Da's Safe Harbor dances over the years. He blazed that trail pretty hard.
Balls harry on a 5% up day...or just stupidly ignorant?
You all should have listened, especially when you all saw the henchmen sent in to silence me with threats to myself and my children. Live and learn in the OTC cesspool. Here's a gift for you GI97845: ACB. Get in now.
Like when you shorted it at $1.50? You should get together with the longs over at INNV. It's called backward investing. You keep shorting AVEO Harry. You'll be nowhere to be found when Dr. Rini speaks at ASCO next month. Do you know what ASCO stands for Harry?
https://www.onclive.com/web-exclusives/tivozanib-improves-pfs-in-highly-refractory-rcc
Rini is the man of RCC. Read paragraph 5 carefully. You too, Harry. LOL
Buying back your $1.50 short at $1.95 Harry? LOL